You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 65 No. 3, MARCH 1940 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

THE BRAIN IN MALIGNANT HYPERTENSION

A CLINICOPATHOLOGIC STUDY

EDWARD F. ROSENBERG, M.D.

Arch Intern Med. 1940;65(3):545-586.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

As a result of the original concepts of Volhard and Fahr,1 a malignant (bösartig) form of hypertension was separated from the general group in 1914. In 1924, however, Wagener and Keith2 described a syndrome of malignant hypertension and showed that this condition deserves the distinction of an entity, differing from chronic glomerulitis and benign hypertension on the basis of age incidence, a characteristic retinal picture, absence of anemia and frequent persistence of adequate renal function. This clinical concept of Wagener and Keith was further developed in investigations at the Mayo Clinic, the results of which were published in 1927,3 1928,4 1929,5 and 1931,6 and various pathologic studies of this disease have been reported from this institution by Cain,7 Morlock8 and Odel.9 None of these works included any comprehensive data regarding the brain. The purpose of the present study has been to survey the brain in cases of malignant hypertension, to . . . [Full Text PDF of this Article]


Author Affiliations

Fellow in Medicine, the Mayo Foundation ROCHESTER, MINN.

From the Division of Medicine, Section of Pathologic Anatomy and Section of Ophthalmology, the Mayo Clinic.


Footnotes

Objection has been raised to the use of the term malignant hypertension. In this paper, the term has been used interchangeably with diffuse arteriolar disease with hypertension, group 4.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1940 American Medical Association. All Rights Reserved.